20/06/2024 Healthcare
Ceftriaxone 1000 mg Sulbactam 500 mg, marketed as Triazo-S 1.5 mg, combines a third-generation cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone inhibits bacterial cell wall synthesis, while Sulbactam inhibits beta-lactamase enzymes produced by some bacteria, enhancing Ceftriaxone's activity against beta-lactamase-producing strains. Triazo-S 1.5 mg is administered intravenously or intramuscularly to treat severe infections caused by susceptible Gram-positive and Gram-negative bacteria. It is prescribed under medical supervision, particularly in infections where beta-lactamase resistance is a concern, ensuring effective therapeutic outcomes.Available in PCD Franchise for injectable range and third party manufacturing.
Amoxyclav 1000 mg/200 mg Injection is a penicillin-type of antibiotic that helps your body fight infections caused by bacteria. It is used to treat in...
Celrim TZ 1000 mg/125 mg Injection is a combination of two antibiotics. It is prescribed to treat various types of bacterial infections. It fights aga...
Binimetinib 15 mg is a highly effective MEK inhibitor used to treat advanced melanoma with BRAF V600 mutations. Binimetinib 15 mg in India is availabl...
Iverheal 12 mg (Ivermectin) is a prescription antiparasitic tablet used to treat scabies, strongyloidiasis, onchocerciasis, head lice, and other paras...
More Details